Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Hepatitis C Treatment Market Snapshot
2.2 Global Hepatitis C Treatment Market, by Drug Type
2.3 Global Hepatitis C Treatment Market Share, by Geography, 2016 (Value %)
Chapter 3 Hepatitis C Treatment Market Analysis
3.1 Global Hepatitis C Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Pipeline Analysis of Hepatitis C Treatment Drugs
3.4 Global Epidemiology of Hepatitis C
3.5 Attractive Investment Proposition
3.6 Competitive Landscape of Key Players in Hepatitis C Treatment Market
Chapter 4 Global Hepatitis C Treatment Market, by Drug Type
4.1 Overview
4.2 Attractive Investment Proposition: Global Hepatitis C Treatment Market, by Drug Type
4.3 Top 3 Countries
4.4 Interferons
4.4.1 Peginterferon alfa-2a
4.4.2 Peginterferon alfa-2b
4.4.3 Interferon alfa-2b
4.5 Ribavirin
4.6 Direct-Acting Antivirals (DAA)
4.6.1 Protease Inhibitor (Paritaprevir, Simepravir, Grazoprevir)
4.6.2 Polymerase Inhibitors
4.6.3 Other Drugs
Chapter 5 Global Hepatitis C Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.2.2 North America Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.3.2 Europe Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.4.1 Asia Pacific Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.4.1 Asia Pacific Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.5.2 Latin America Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Hepatitis C Treatment Market, by Drug Type, 2015- 2025 (US$)
5.6.2 Middle East and Africa Hepatitis C Treatment Market, by Country, 2015- 2025 (US$)
Chapter 6 Company Profiles
6.1 AbbieVie Inc.
6.2 Bristol-Myers Squibb Company
6.3 F. Hoffmann-La Roche AG
6.4 Gilead Sciences Inc.
6.5 GlaxoSmith Kline Plc.
6.6 Janssen Pharmaceuticals Inc.
6.7 Merck & Co. Inc.
6.8 Schering AG
6.9 Vertex Pharmaceuticals
List of Figures
FIG. 1 Hepatitis C Treatment Market: Research Methodology
FIG. 2 Global Hepatitis C Treatment Market, by Drug Type, 2016 (US$ Bn)
FIG. 3 Global Hepatitis C Treatment Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Hepatitis C Treatment Market, by Geography, 2016
FIG. 5 Attractive Investment Proposition: Global Hepatitis C Treatment Market, by Drug type, 2016
FIG. 6 Global Peginterferon alfa-2a Market, 2015 – 2025 (US$ Bn)
FIG. 7 Global Peginterferon alfa-2b Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Interferon alfa-2b Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Ribavirin Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Protease Inhibitor Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Polymerase Inhibitors Market, 2015 – 2025 (US$ Bn)
FIG. 12 Global Other Drugs Market, 2015 – 2025 (US$ Bn)
List of Tables
TABLE 1 Market Positioning of Key Players in Global Hepatitis C Treatment Market
TABLE 2 Global Hepatitis C Treatment Market, by Drug Type, 2015 – 2025 (US$ Bn)
TABLE 3 Top 3 Countries in Global Hepatitis C Treatment Market, 2015 – 2025 (US$ Bn)
TABLE 4 Global Interferons Market in Hepatitis C Treatment, 2015 – 2025 (US$ Bn)
TABLE 5 Global Direct-Acting Antivirals (DAA) Market, 2015 – 2025 (US$ Bn)
TABLE 6 Global Hepatitis C Treatment Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 7 North America Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 8 North America Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Europe Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 10 Europe Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 11 Asia Pacific Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 12 Asia Pacific Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Latin America Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 14 Latin America Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 15 Middle East and Africa Hepatitis C Treatment Market, by Drug Type, 2015-2025 (US$ Bn)
TABLE 16 Middle East and Africa Hepatitis C Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 17 AbbieVie Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 18 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 19 F. Hoffmann-La Roche AG: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 20 Gilead Sciences Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 21 GlaxoSmith Kline Plc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 22 Janssen Pharmaceuticals Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 23 Merck & Co. Inc.: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 24 Schering AG: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)
TABLE 25 Vertex Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Drug Position/Portfolio; News Coverage)